ALKERMES reported $1.65M in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Amgen AMGN:US $ 31877M 71M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.68M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Coherus Biosciences CHRS:US $ 0.01M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
H. Lundbeck A/S LUN:DC 996M 0
Heron Therapeutics HRTX:US $ 1.02M 0.1M
Horizon Pharma HZNP:US $ 0.02M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
JAZZ PHA JAZZ:US $ 0.06M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Minerva Neurosciences NERV:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Otsuka Holdings 4578:JP Y 81690M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Revance Therapeutics RVNC:US $ 0.07M 0M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M
Zogenix ZGNX:US $ 0M 0M